Automate 40% of encounters through smarter clinical and payer insights
Why R1
Every encounter. Continuously evaluated.
Clinical evidence and payer-specific risk, evaluated together
Evaluate clinical evidence and payer-specific risk through distinct lenses in real-time to reveal where a case may still be vulnerable to downstream denial.
100% review, from admission to discharge
Continuously review every case to surface clinical complexity and payer-specific risk as the record changes.
Guidance calibrated to your environment
Built around your health system. Guidance reflects your payer mix and denial tolerance — not a generic default.
Where AI and clinical expertise meet
Identify which cases carry real risk, extending how many your team can meaningfully cover. The recommendation is a starting point — a clinician decides what happens next.
The Guthrie Clinic is among the first health systems adopting Phare UM to enhance utilization management processes and proactively address denial risk.
Beyond clinical criteria: see the payer risk that clinical scores miss.
In a retrospective analysis of a multi-state health system's open inpatient denial inventory, Phare UM helped teams identify the clinical nuance to get it right the first time and the evidence to win the appeal when they don't — driving fewer medical necessity denials, reduced revenue leakage, and stronger clinician productivity.
69% vs. 99% for score-based tools
Confidence ≠ correctness
On the same denied inpatient population, a common scoring UM tool called 99% “safe to bill inpatient.” Phare UM flagged only 69%, catching nearly 30 more points of real denial risk pre-billing.
41% of open denied AR
Insights that prevent, not just predict
Applied retrospectively to the health system’s open denial inventory, Phare UM surfaced documentation-level risk insight on 41% of the balance, the population a proactive workflow would resolve pre-bill.
Evidence-based from general assertion to cited proof
Sharper evidence when appeal is needed
On accounts still requiring appeal, Phare UM adds sourced clinical criteria and regulatory citations, turning a general necessity claim into a two-pronged case payers can’t easily dismiss.
Phare UM is powered by Phare OS, R1’s AI-native revenue operating system, so every payer outcome and peer-to-peer result sharpens the next recommendation.
Every outcome makes the next UM decision smarter
Phare UM feeds payer decisions, peer-to-peer results, and denial outcomes back into Phare OS, so recommendations keep improving across similar cases, payers, and clinical patterns. Your team moves from reactive case review to proactive denial prevention, with clinical expertise and consistency built into every decision.